Cardiff Oncology Inc. (CRDF) Stock Price

2.275 ▲ +0.165 (+7.82%)
Open: 2.09 Vol: 0 Day's range: 2.09 - 2.28 Nov 26, 11:37 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Loading chart ...
CRDF Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.26▼ 2.24▲ 2.19▲ 2.09▲ 2.19▲
MA10 2.26▼ 2.16▲ 2.14▲ 2.08▲ 2.18▲
MA20 2.25▲ 2.13▲ 2.10▲ 2.17▲ 2.41▼
MA50 2.17▲ 2.06▲ 2.05▲ 2.18▲ 3.12▼
MA100 2.13▲ 2.06▲ 2.13▲ 2.49▼ 3.02▼
MA200 2.07▲ 2.14▲ 2.19▲ 2.94▼ 2.40▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.005▼ 0.018▲ 0.021▲ 0.003▲ 0.019▲
RSI 60.553▲ 76.337▲ 72.994▲ 56.032▲ 43.936▼
STOCH 64.286     91.589▲ 80.339▲ 40.217     49.726    
WILL %R -85.714▼ -14.286▲ -12.766▲ -18.605▲ -38.596    
CCI -80.694     129.531▲ 190.311▲ 64.001     20.474    
Latest Filters Detected On CRDF
RSI&MACD $CRDF MACD cross and RSI above 55 Set Alert
RSI $CRDF RSI(14) Crossed Above 50 Set Alert
MACD $CRDF MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $CRDF Price Crossed Above MA(50) Set Alert
MA $CRDF Price Crossed Above MA(26) Set Alert
MA $CRDF Price Crossed Above MA(13) Set Alert
Cardiff Oncology Inc. News
Monday, November 24, 2025 04:15 AM
Presenters: Mark Erlander, PhD (CEO) Date: 12/02/2025 Time: 9:30 AM ET Interested parties can register for and access the live webcast for the conferences by visiting the “ Events ” section of the ...
Thursday, November 20, 2025 12:39 PM
Announced positive data from the ongoing Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer – – Expects to report ...
Thursday, November 06, 2025 08:05 AM
– Announced positive data from the ongoing Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer – – Expects to ...
CRDF historical stock data
date open high low close volume
26/11/25 2.09 2.28 2.09 2.25 538,621
25/11/25 2.10 2.12 2.07 2.11 464,200
24/11/25 2.03 2.11 2.03 2.08 535,500
21/11/25 1.96 2.04 1.90 2.03 1,234,500
20/11/25 2.03 2.10 1.95 1.96 850,800
19/11/25 2.02 2.06 1.96 2.00 826,800
18/11/25 2.07 2.0987 1.99 2.04 1,045,150
17/11/25 2.10 2.165 2.035 2.06 859,446
14/11/25 2.14 2.19 2.09 2.13 814,400
13/11/25 2.24 2.25 2.14 2.15 916,237
Quote Details
52wk Low:1.90
52wk High:5.64
Vol:0
Avg Vol(3m):17.5M
1Y Chng:-31.19%
1M Chng:+0.45%
Add to Watch List